Resmed Inc RMD
📋 Company Profile
| Industry | Health Care |
| Country | US |
| Exchange | NEW YORK STOCK EXCHANGE, INC. |
| Currency | USD |
| IPO Date | 1995-06-01 |
| Shares Out. | 145,060,000 |
| Website | resmed.com/ ↗ |
| Phone | 13026365400 |
| Employees | 10,600 |
| Revenue | $1.43B |
| Gross Profit | $898.8M |
| Net Income | $398.7M |
| Free Cash Flow | $1.75B |
| Total Assets | $8.78B |
| Total Liabilities | $2.29B |
| Equity | $6.49B |
About Resmed Inc
ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks, and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with aging populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two-thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan, and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor, and payer in the out-of-hospital setting.
Resmed Inc is a publicly traded company under the ticker symbol RMD on the NEW YORK STOCK EXCHANGE, INC., operating in the Health Care industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
25 analysts (2026-07-01)
